Assignee
NAT INSTITUTE OF IMMUNOLOGY
IN·4 granted patents·9 pending applications·0 citations·filing 2017–2023
Top patents by PatentIndex Score
13 records- 0165US2025195468A1Methods and compositions for treating colorectal cancer with indoxyl sulfateNAT INSTITUTE OF IMMUNOLOGY·Filed 2023·Application pending·0 cites
- 0258US2024180881A1Methods for decreasing resistance to chemotherapyNAT INSTITUTE OF IMMUNOLOGY·Filed 2023·Application pending·0 cites
- 0350US2024002424A1Hexosamine compounds and methods thereofNAT INSTITUTE OF IMMUNOLOGY·Filed 2022·Application pending·0 cites
- 0449US2025376681A1Mir449a as a therapeutic for neurodegenerative disordersNAT INSTITUTE OF IMMUNOLOGY·Filed 2023·Application pending·0 cites
- 0548US11957692B2Clomipramine for the treatment of Alzheimer's DiseaseNAT INSTITUTE OF IMMUNOLOGY·Filed 2022·Granted Apr 16, 2024·0 cites·17 claims
- 0648US2022339180A1Methods And Compositions For Treating Viral Diseases Using Combination Of DrugsNAT INSTITUTE OF IMMUNOLOGY·Filed 2021·Application pending·0 cites
- 0747US2023407401A1Dna damage dependent microrna signature for cancers, methods and uses related theretoNAT INSTITUTE OF IMMUNOLOGY·Filed 2020·Application pending·0 cites
- 0846US11485714B2Hydroxyethylamine-based piperazine compounds, and methods of producing and using the same for treating diseaseNAT INSTITUTE OF IMMUNOLOGY·Filed 2021·Granted Nov 1, 2022·0 cites·19 claims
- 0946US11447534B2Peptide complex with immunodulatory and anti-inflammatory functionNAT INSTITUTE OF IMMUNOLOGY·Filed 2019·Granted Sep 20, 2022·0 cites·11 claims
- 1044US11820764B2Compound modulating GSK-3 activityNAT INSTITUTE OF IMMUNOLOGY·Filed 2021·Granted Nov 21, 2023·0 cites·2 claims
- 1141US2022008449A1A method of mimicking benefits of dietary restriction by transiently upregulating er stress responseNAT INSTITUTE OF IMMUNOLOGY·Filed 2019·Application pending·0 cites
- 1239US2022175888A1Carboxylated osteocalcin for treatment of amyloidosis or diseases associated with abnormal protein foldingNAT INSTITUTE OF IMMUNOLOGY·Filed 2019·Application pending·0 cites
- 1337US2019134177A1Conjugate for vaccination against typhoid comprising chemical conjugate of vi polysaccharide and flagellin, a process for producing the same and a composition comprising the conjugateNAT INSTITUTE OF IMMUNOLOGY·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NAT INSTITUTE OF IMMUNOLOGY files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →